Apoptotic susceptibility of cancer cells selected for camptothecin resistance: Gene expression profiling, functional analysis, and molecular interaction mapping

Cancer Research

Volumn 63, Issue 5, 2003, Pages 1000-1011

  Reinhold, William C ^a   Kouros Mehr, Hosein ^a,d   Kohn, Kurt W ^a   Maunakea, Alika K ^a   Lababidi, Samir ^a   Roschke, Anna ^a   Stover, Kristen ^a   Alexander, Jes ^a   Pantazis, Panayotis ^b   Miller, Lance ^a,e   Liu, Edison ^a,e   Kirsch, Ilan R ^a   Urasaki, Yoshimasa ^a,c   Pommier, Yves ^a   Weinstein, John N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF FUKUI   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CISPLATIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; STAUROSPORINE; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MAPPING; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037374548     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Pommier, Y., Pourquier, P., Urasaki, Y., Wu, J., and Laco, G. Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resistance Update, 2: 307-318, 1999.
2. Chen, A. Y., and Liu, L. F. DNA Topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol., 94: 194-218, 1994.
3. Beck, W. T., Khelifa, T., Kusumoto, H., Mo, Y. Y., Rodgers, Q., Wolverton, J. S., and Wang, Q. Novel mechanisms of resistance to inhibitors of DNA topoisomerases. Adv. Enzyme Regul., 37: 17-26, 1997.
4. Nieves-Neira, W., and Pommier, Y. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the eight human breast cancer cell lines of the NCI anticancer drug screen: multifactorial relationship with topoisomerase I, protein kinase C, bcl-2 and caspase pathways. Int. J. Cancer, 82: 396-404, 1999.
5. Urasaki, Y., Laco, G., Pourquier, P., Takebayashi, Y., Kohlhagen, G., Gioffre, C., Zhang, H., Chatterjee, D., Pantazis, P., and Pommier, Y. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line. Cancer Res., 61: 1964-1969, 2001.
6. Weinstein, I. B. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science (Wash. DC), 297: 63-64, 2002.
7. Rasmussen, L. J., Rasmussen, M., Lutzen, A., Bisgaard, H. C., and Singh, K. K. The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents. Exp. Cell Res., 257: 127-134, 2000.
8. Chen, Y., Wang, J., Fraig, M. M., Metcalf, J., Turner, W. R., Bissada, N. K., Watson, D. K., and Schweinfest, C. W. Defects of DNA mismatch repair in human prostate cancer. Cancer Res., 61: 4112-4121, 2001.
9. Costa-Pereira, A. P., and Cotter, T. G. Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis. Br. J. Cancer, 80: 371-378, 1999.
10. Tang, D. G., Li, L., Chopra, D. P., and Porter, A. T. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res., 58: 3466-3479, 1998.
11. Chatterjee, D., Schmitz, I., Krueger, A., Yeung, K., Kirchhoff, S., Krammer, P. H., Peter, M. E., Wyche, J. H., and Pantazis, P. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLiP(short). Cancer Res., 61: 7148-7154, 2001.
12. Nimmanapalli, R., Perkins, C. L., Orlando, M., O'Bryan, E., Nguyen, D., and Bhalla, K. N. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res., 61: 759-763, 2001.
13. Chatterjee, D., Wyche, J. H., and Pantazis, P. Induction of apoptosis in malignant and camptothecin-resistant human cells. Ann. N. Y. Acad. Sci., 803: 143-156, 1996.
14. Zhou, Y., Gwadry, F. G., Reinhold, W. C., Miller, L. D., Smith, L. H., Scherf, U., Liu, E. T., Kohn, K. W., Pommier, Y., and Weinstein, J. N. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: Microarray analysis of dose- and time-dependent effects. Cancer Res., 62: 1688-1695, 2002.
15. Agresti, A. Categorical Data Analysis. John Wiley & Sons, Inc., 1990.
16. Kohn, K. W. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell, 10: 2703-2734, 1999.
17. Tanabe, L., Scherf, U., Smith, L. H., Lee, J. K., Hunter, L., and Weinstein, J. N. MedMiner: an Internet text-mining tool for biomedical information, with application to gene expression profiling. Biotechniques. 27: 1210-1214, 1216-1217, 1999.
18. Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nonomura, Y., and Matsuda, Y. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem., 268: 25846-25856, 1993.
19. Li, X., Marani, M., Mannucci, R., Kinsey, B., Andriani, F., Nicoletti, I., Denner, L., and Marcelli, M. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res., 61: 1699-1706, 2001.
20. Tafani, M., Minchenko, D. A., Serroni, A., and Farber, J. L. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res., 61: 2459-2566, 2001.
21. Jan, M. S., Liu, H. S., and Lin, Y. S. Bad overexpression sensitizes NIH/3T3 cells to undergo apoptosis which involves caspase activation and ERK inactivation. Biochem. Biophys. Res. Commun., 264: 724-729, 1999.
22. Ding, Z., Yang, X., Pater, A., and Tang, S. C. Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells. Biochem. Biophys. Res. Commun., 270: 415-420, 2000.
23. Ao, Y., Rohde, L. H., and Naumovski, L. p53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis. Oncogene, 20: 2720-2725, 2001.
24. Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., and Cheresh, D. A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol., 155: 459-470, 2001.
25. Danilkovitch-Miagkova, A., Angeloni, D., Skeel, A., Donley, S., Lerman, M., and Leonard, E. J. Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src. J. Biol. Chem., 275: 14783-14786, 2000.
26. Danilkovitch-Miagkova, A., and Leonard, E. J. Anti-apoptotic action of macrophage stimulating protein (MSP). Apoptosis. 6: 183-190, 2001.
27. Sarma, V., Lin, Z., Clark, L., Rust, B. M., Tewari, M., Noelle, R. J., and Dixit, V. M. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem., 270: 12343-12346, 1995.
28. Chu, Z. L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., and Ballard, D. W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA, 94: 10057-10062, 1997.
29. Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., and Ma, A. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science (Wash. DC), 289: 2350-2354, 2000.
30. Nozaki, S., Sledge G. W., Jr., and Nakshatri, H. Repression of GADD153/CHOP by NF-κB: a possible cellular defense against endoplasmic reticulum stress-induced cell death. Oncogene, 20: 2178-2185, 2001.
31. McCullough, K. D., Martindale, J. L., Klotz, L. O., Aw, T. Y., and Holbrook, N. J. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol., 21: 1249-1259, 2001.
32. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., and Tschopp, J. NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol., 21: 5299-5305, 2001.
33. Chapman, N. R., and Perkins, N. D. Inhibition of the RelA(p65) NF-κB subunit by Egr-1. J. Biol. Chem., 275: 4719-4725, 2000.
34. Massague, J., Blain, S. W., and Lo, R. S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell. 103: 295-309, 2000.
35. Das, A., Chendil, D., Dey, S., Mohiuddin, M., Mohiuddin, M., Milbrandt, J., Rangnekar, V. M., and Ahmed, M. M. Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis. J. Biol. Chem., 276: 3279-3286, 2001.
36. Virolle, T., Adamson, E. D., Baron, V., Birle, D., Mercola, D., Mustelin, T., and de Belle, I. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol., 3: 1124-1128, 2001.
37. Uchida, K., Suzuki, H., Ohashi, T., Nitta, K., Yumura, W., and Nihei, H. Involvement of MAP kinase cascades in Smad7 transcriptional regulation. Biochem. Biophys. Res. Commun., 289: 376-381, 2001.
38. Mazars, A., Lallemand, F., Prunier, C., Marais, J., Ferrand, N., Pessah, M., Cherqui, G., and Atfi, A. Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J. Biol. Chem., 276: 36797-36803, 2001.
39. Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Komprost, M, Gallea, S., Roman-Roman, S., Cherqui, G., and Atfi, A. Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells. Oncogene, 20: 879-884, 2001.
40. Weston, C. R., and Davis, R. J. The JNK signal transduction pathway. Curr. Opin. Genet. Dev., 12: 14-21, 2002.
41. Potapova, O., Basu, S., Mercola, D., and Holbrook, N. J. Protective role for c-Jun in the cellular response to DNA damage. J. Biol. Chem., 276: 28546-28553, 2001.
42. Leppa, S., Eriksson, M., Saffrich, R., Ansorge, W., and Bohmann, D. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Mol. Cell. Biol., 21: 4369-4378, 2001.
43. Lee, L. F., Li, G., Templeton, D. J., and Ting, J. P. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J. Biol. Chem., 273: 28253-28260, 1998.
44. Blattner, C., Kannouche, P., Litfin, M., Bender, K., Rahmsdorf, H. J., Angulo, J. F., and Herrlich, P. UV-Induced stabilization of c-fos and other short-lived mRNAs. Mol. Cell. Biol., 20: 3616-3625, 2000.
45. Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., and Weinberg, R. A, TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol., 3: 708-714, 2001.
46. Lin, D. Y., and Shih, H. M. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration. J. Biol. Chem. 277: 25446-25456, 2002.
47. Fleischmann, A., Hafezi, F., Elliott, C., Reme, C. E., Ruther, U., and Wagner, E. F. Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev., 14: 2695-2700, 2000.
48. Leone, G., Sears, R., Huang, E., Rempel, R., Nuckolls, F., Park, C. H., Giangrande, P., Wu, L., Saavedra, H. I., Field, S. J., Thompson, M. A., Yang, H., Fujiwara, Y., Greenberg, M. E., Orkin, S., Smith, C., and Nevins, J. R. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell, 8: 105-113, 2001.
49. Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., and Kato, M. c-myc is a downstream target of the Smad pathway. J. Biol. Chem., 277: 854-861, 2002.
50. Eischen, C. M., Packham, G., Nip, J., Fee, B. E., Hiebert, S. W., Zambetti, G. P., and Cleveland, J. L. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene, 20: 6983-6993, 2001.
51. Soucie, E. L., Annis, M. G., Sedivy, J., Filmus, J., Leber, B., Andrews, D. W., and Penn, L. Z. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol. Cell. Biol., 21: 4725-4736, 2001.
52. Goto, S., Ihara, Y., Urata, Y., Izumi, S., Abe, K., Koji, T., and Kondo, T. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase π. FASEB J., 15: 2702-2714, 2001.
53. Adler, V., Yin, Z., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., Pincus, M. R., Sardana, M., Henderson, C. J., Wolf, C. R., Davis, R. J., and Ronai, Z. Regulation of JNK signaling by GSTp. EMBO J., 18: 1321-1334, 1999.
54. Strange, R. C., Spiteri, M. A., Ramachandran, S., and Fryer, A. A. Glutathione-S-transferase family of enzymes. Mutat. Res., 482: 21-26, 2001.
55. Borde-Chiche, P., Diederich, M., Morceau, F., Wellman, M., and Dicato, M. Phorbol, ester responsiveness of the glutathione S-transferase Pl gene promoter involves an inducible c-jun binding in human K562 leukemia cells. Leuk. Res., 25: 241-247, 2001.
56. Young, M. R., Nair, R., Bucheimer, N., Tulsian, P., Brown, N., Chapp, C., Hsu, T. C., and Colburn, N. H. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol., 22: 587-598, 2002.
57. Nelson, W. G., De Marzo, A. M., Deweese, T. L., Lin, X., Brooks, J. D., Putzi, M. J., Nelson, C. P., Groopman, J. D., and Kensler, T. W. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Ann. N. Y. Acad. Sci., 952: 135-144, 2001.
58. Song, J. Z., Stirzaker, C., Harrison, J., Melki, J. R., and Clark, S. J. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene, 21: 1048-1061, 2002.
59. Lin, X., Asgari, K., Putzi, M. J., Gage, W. R., Yu, X., Cornblatt, B. S., Kumar, A., Piantadosi, S., DeWeese, T. L., De Marzo, A. M., and Nelson, W. G. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with-procainamide. Cancer Res., 61: 8611-8616, 2001.
60. Sanjay, A., Fu, J., and Kreibich, G. DADI is required for the function and the structural integrity of the oligosaccharyltransferase complex. J. Biol. Chem., 273: 26094-26099, 1998.
61. Yoshimi, M., Sekiguchi, T., Hara, N., and Nishimoto, T. Inhibition of N-linked glycosylation causes apoptosis in hamster BHK21 cells. Biochem. Biophys. Res. Commun., 276: 965-969, 2000.
62. Hickman, J. A. Apoptosis and tumourigenesis. Curr. Opin. Genet. Dev., 12: 67-72, 2002.
63. Kartner, N., Riordan, J. R., and Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (Wash. DC) 221: 1285-1288, 1983.
64. Hoki, Y., Fujimori, A., and Pommier, Y. Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein-overexpressing cell lines. Cancer Chemother. Pharmacol., 40: 433-438, 1997.
65. Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fomace, A. J., Jr., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., Buolamwini, J. K., van Osdol, W. W., Monks, A. P., Scudiero, D. A., Sausville, E. A., Zaharevitz, D. W., Bunow, B., Viswanadhan, V. N., Johnson, G. S., Wittes, R. E., and Paull, K. D. An information-intensive approach to the molecular pharmacology of cancer. Science (Wash. DC), 275: 343-349, 1997.
66. Weinstein, J. N. Fishing expeditions. Science (Wash. DC), 282: 627, 1998.
67. Weinstein, J. N. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Curr. Opin. Pharmacol., 2: 361-365, 2002.
68. Luscher, B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene, 277: 1-14, 2001.